Venture Life Group Plc (VLG)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Venture Life Group Plc (VLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013380
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The company’s product range and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin. It also offers development and manufacturing services to companies in the medical device and cosmetic sectors. Venture Life conducts research in the therapeutic areas of cardiovascular, neurology, dermatology, rheumatology and ophthalmology. The company markets its products in the UK and abroad. Venture Life is headquartered in Bracknell, the UK.

Venture Life Group Plc (VLG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Venture Life Group Plc, Medical Devices Deals, 2011 to YTD 2017 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Venture Life Enters into Distribution Agreement with Moorfields Pharma 15
Equity Offering 16
Venture Life Group Raises USD9 Million in IPO 16
Acquisition 17
Venture Life Group Acquires Biokosmes 17
Venture Life Group Plc – Key Competitors 18
Venture Life Group Plc – Key Employees 19
Venture Life Group Plc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Venture Life Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Venture Life Group Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Venture Life Group Plc, Medical Devices Deals, 2011 to YTD 2017 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Venture Life Enters into Distribution Agreement with Moorfields Pharma 15
Venture Life Group Raises USD9 Million in IPO 16
Venture Life Group Acquires Biokosmes 17
Venture Life Group Plc, Key Competitors 18
Venture Life Group Plc, Key Employees 19
Venture Life Group Plc, Subsidiaries 20

★海外企業調査レポート[Venture Life Group Plc (VLG)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Beacon Insurance Company Limited:企業の戦略・SWOT・財務分析
    The Beacon Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Beacon Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析
    Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • MicuRx Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. Its lead produc …
  • Landis+Gyr AG:企業の戦略的SWOT分析
    Landis+Gyr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Coeur Mining, Inc:企業のM&A・事業提携・投資動向
    Coeur Mining, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coeur Mining, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Medicago Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a biopharmaceutical company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline …
  • Adamis Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    Adamis Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Adamis Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Aeterna Zentaris Inc (AEZS):医療機器:M&Aディール及び事業提携情報
    Summary Aeterna Zentaris Inc (Aeterna Zentaris) is a specialty biopharmaceutical company that focuses on the development and commercialization of novel pharmaceutical therapies for the treatment of endocrine disorders. The company’s lead product, macimorelin, a ghrelin receptor agonist and orally-ac …
  • DexCom Inc (DXCM):企業の製品パイプライン分析
    Summary Dexcom Inc (Dexcom) is a medical device company that designs, develops and commercializes continuous glucose monitoring (CGM) systems. The company’s major products include integrated CGM systems for adults and pediatric use, Dexcom G5 mobile CGM system, Dexcom G4 PLATINUM CGM system, associa …
  • National Power Corporation:電力:M&Aディール及び事業提携情報
    Summary National Power Corporation (Napocor) is a government owned utility. It develops hydroelectric generation plants; produces power from nuclear, geothermal, and other sources; and transmits electricity across the country. The corporation preserves and protects the dams and watershed. Napocor’s …
  • Yamaha Motor Co Ltd (7272):企業の財務・戦略的SWOT分析
    Yamaha Motor Co Ltd (7272) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Olink Proteomics AB:医療機器:M&Aディール及び事業提携情報
    Summary Olink Proteomics AB (Olink) is a biotechnology company that offers products and services for human protein biomarker research. The company provides portfolio of products such as biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. …
  • Sumitomo Metal Mining Co Ltd:戦略・SWOT・企業財務分析
    Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NRW Holdings Ltd:企業の戦略・SWOT・財務情報
    NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tyson Fresh Meats Inc:企業の戦略・SWOT・財務情報
    Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Arix Bioscience Plc (ARIX):企業の財務・戦略的SWOT分析
    Arix Bioscience Plc (ARIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Aeroflot OAO:企業の戦略・SWOT・財務情報
    Aeroflot OAO - Strategy, SWOT and Corporate Finance Report Summary Aeroflot OAO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Vertical Computer Systems Inc (VCSY):企業の財務・戦略的SWOT分析
    Summary Vertical Computer Systems Inc (VCSY) is a technology company that develops and markets of application software, cloud-based and software services, internet core technologies, and intellectual property assets. The company provides products such as siteflash, responseflash, empath, snappnet, a …
  • ValiRx Plc (VAL)-医療機器分野:企業M&A・提携分析
    Summary ValiRx Plc (ValiRx) is a biopharmaceutical company that develops technologies and therapeutic options for the treatment of cancer. The company’s products and technology include GeneICE-silencing rebellious genes, GeneICE – BCL-2, VAL201-prostate cancer, NAV3 cancer screening test and VAL401- …
  • Wesco Aircraft Holdings Inc:企業の戦略・SWOT・財務分析
    Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆